CompoAtlas

macérat glycériné concentré de prele

Food supplement declared in France, declaration No 2018-1-4, decision dated 1 January 2018

macérat glycériné concentré de prele, from Monsieur Bousquet Michael, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Equisetum arvense 0.75 ml per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
Monsieur Bousquet Michael
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
15 gouttes
Objectives stated by the manufacturer (these are not authorised claims)
Bones, Joints

Declaration 152880, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Equisetum arvense L.Jeune pousseAutre macérât0.75 ml

Additives

E422

Other ingredients

Alcool éthylique, Eau purifiée

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “macérat glycériné concentré de prele: composition and regulation”, https://compoatlas.com/en/supplements/products/152880-macerat-glycerine-concentre-de-prele, updated 15 November 2026.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line